# Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02064764` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02064764](<https://clinicaltrials.gov/study/NCT02064764>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02064764

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

## Technical summary

Registry record NCT02064764. Randomized; no masking; primary purpose treatment. Start 2015-02 (actual); primary completion 2021-04-19 (actual). Results posted on 2024-02-23.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 102 participants (enrolled count; ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Started: 2015-02 (actual) (ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Primary completion: 2021-04-19 (actual) (ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Completion: 2021-04-19 (actual) (ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Results first posted: 2024-02-23 (ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Countries: United States; Germany (ClinicalTrials.gov record NCT02064764, source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02064764-2024-02-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
- Acronym: Symplicity AF
- Condition: Atrial Fibrillation
- Condition: Hypertension
- Intervention (Device): Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter
- Intervention (Device): Arctic Front Advance™ Cardiac Cryoablation System
- Lead sponsor: Medtronic Vascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Medtronic Vascular (`cardio:org-medtronic-vascular`)

## Provenance

Content hash: e54a91f757acd4a5f9375a59fcda9e2c17001081f12e3880f2477de03e9a3214
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
